How Institutional Funds Moved on NVAX

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP increased this position by 670% ($5,004,464 -> $38,537,625). 2026-06-30
MILLENNIUM MANAGEMENT LLC MILLENNIUM MANAGEMENT LLC reduced this position by 99% ($31,359,716 -> $211,950). 2026-06-30
Sanofi Sanofi increased this position by 40% ($46,236,832 -> $64,814,131). 2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC VANGUARD PORTFOLIO MANAGEMENT LLC increased this position by 23% ($58,214,228 -> $71,667,322). 2026-06-30
Sixth Street Partners Management Company, L.P. Sixth Street Partners Management Company, L.P. opened a new position worth $12,685,038. 2026-06-30
RENAISSANCE TECHNOLOGIES LLC RENAISSANCE TECHNOLOGIES LLC increased this position by 17% ($4,048,698 -> $4,726,796). 2026-06-30
JUPITER ASSET MANAGEMENT LTD JUPITER ASSET MANAGEMENT LTD opened a new position worth $10,081,585. 2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC VANGUARD CAPITAL MANAGEMENT LLC increased this position by 18% ($58,039,397 -> $68,365,170). 2026-06-30

Which Funds Hold NVAX

Largest reported positions as of 2026-06-30.

FundValueShares
SHAH CAPITAL MANAGEMENT $133,439,735 14,165,577
VANGUARD PORTFOLIO MANAGEMENT LLC $71,667,322 7,607,996
VANGUARD CAPITAL MANAGEMENT LLC $68,365,170 7,257,449
Sanofi $64,814,131 6,880,481
TWO SIGMA INVESTMENTS, LP $38,537,625 4,091,043
COATUE MANAGEMENT LLC $36,144,408 3,836,986
GEODE CAPITAL MANAGEMENT, LLC $34,061,945 3,615,026
BANK OF AMERICA CORP /DE/ $24,233,016 2,572,507
Sculptor Capital LP $24,107,778 20,252,000
GOLDMAN SACHS GROUP INC $18,054,901 1,916,656

Data compiled from public SEC filings. This is informational reporting, not investment advice.

Sanofi’s 13F Portfolio Moves, Tracked Quarter by Quarter

Table-style overview of Sanofi's 13F portfolio changes for the quarter ending June 30, 2026, showing new positions in AGMB, ODTX, and TRAX, increases in MGTX, NVAX, INBX, MPLT, ANAB, and QTTB, a reduction in IMRX, and an exit from Eledon.

This page tracks Sanofi’s institutional portfolio activity as disclosed in its quarterly Form 13F filings with the SEC. Rather than a one-off news snapshot, think of it as a running ledger — new positions, exits, and size changes get logged here every quarter so you can see how the company’s biotech and pharma stakes shift … Read more